Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Czarina N. Behrends, Sarah Gutkind, Emily Winkelstein, Monique Wright, Jennifer Dolatshahi, Alice Welch, Denise Paone, Hillary V. Kunins & Bruce R. Schackman. (2022) Costs of opioid overdose education and naloxone distribution in New York City. Substance Abuse 43:1, pages 692-698.
Read now
Read now
Shane R. Mueller, Alexander Y. Walley, Susan L. Calcaterra, Jason M. Glanz & Ingrid A. Binswanger. (2015) A Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community Programming Into Clinical Practice. Substance Abuse 36:2, pages 240-253.
Read now
Read now
Articles from other publishers (26)
Sheila V. Patel, Lynn D. Wenger, Alex H. Kral, Kenneth Sherr, Anjuli D. Wagner, Peter J. Davidson & Barrot H. Lambdin. (2023) Optimizing naloxone distribution to prevent opioid overdose fatalities: results from piloting the Systems Analysis and Improvement Approach within syringe service programs. BMC Health Services Research 23:1.
Crossref
Crossref
Phillip O. Coffin, Sigal Maya & James G. Kahn. (2022) Modeling of overdose and naloxone distribution in the setting of fentanyl compared to heroin. Drug and Alcohol Dependence 236, pages 109478.
Crossref
Crossref
Nelda Cherrier, Joanne Kearon, Robin Tetreault, Sophiya Garasia & Emmanuel Guindon. (2021) Community Distribution of Naloxone: A Systematic Review of Economic Evaluations. PharmacoEconomics - Open 6:3, pages 329-342.
Crossref
Crossref
John Strang. (2022) Take-Home Naloxone and the Prevention of Deaths from Heroin Overdose: Pursuing Strong Science, Fuller Understanding, Greater Impact. European Addiction Research 28:3, pages 161-175.
Crossref
Crossref
Magdalena Cerdá, Mohammad S Jalali, Ava D Hamilton, Catherine DiGennaro, Ayaz Hyder, Julian Santaella-Tenorio, Navdep Kaur, Christina Wang & Katherine M Keyes. (2021) A Systematic Review of Simulation Models to Track and Address the Opioid Crisis. Epidemiologic Reviews 43:1, pages 147-165.
Crossref
Crossref
Amir RazaghizadSarah B. WindleKristian B. FilionGenevieve GoreIrina KudrinaElena ParaskevopoulosJonathan KimmelmanMarc O. MartelMark J. Eisenberg. (2021) The Effect of Overdose Education and Naloxone Distribution: An Umbrella Review of Systematic Reviews. American Journal of Public Health 111:8, pages e1-e12.
Crossref
Crossref
Birgitte Thylstrup, Morten Hesse, Marian Jørgensen & Henrik Thiesen. (2019) One opioid user saving another: the first study of an opioid overdose-reversal and naloxone distribution program addressing hard-to-reach drug scenes in Denmark. Harm Reduction Journal 16:1.
Crossref
Crossref
Samantha Colledge, Amy Peacock, Janni Leung, Sarah Larney, Jason Grebely, Matthew Hickman, Evan Cunningham, Adam Trickey, Jack Stone, Peter Vickerman & Louisa Degenhardt. (2019) The prevalence of non-fatal overdose among people who inject drugs: A multi-stage systematic review and meta-analysis. International Journal of Drug Policy 73, pages 172-184.
Crossref
Crossref
Lynn D. Wenger, David Showalter, Barrot Lambdin, David Leiva, Eliza Wheeler, Peter J. Davidson, Phillip O. Coffin, Ingrid A. Binswanger & Alex H. Kral. (2019) Overdose Education and Naloxone Distribution in the San Francisco County Jail. Journal of Correctional Health Care 25:4, pages 394-404.
Crossref
Crossref
Juliana H. Zschoche, Suzanne Nesbit, Umbreen Murtaza, Amanda Sowell, Julie M. Waldfogel, Nicole Arwood, Jordan Rush, LeAnn McNamara, Meghan Swarthout, Todd Nesbit & Melinda Ortmann. (2018) Development and implementation of procedures for outpatient naloxone prescribing at a large academic medical center. American Journal of Health-System Pharmacy 75:22, pages 1812-1820.
Crossref
Crossref
Lauren E. Cipriano & Gregory S. Zaric. (2018) Cost-effectiveness of naloxone kits in secondary schools. Drug and Alcohol Dependence 192, pages 352-361.
Crossref
Crossref
Javier A Cepeda, Ksenia Eritsyan, Peter Vickerman, Alexandra Lyubimova, Marina Shegay, Veronika Odinokova, Leo Beletsky, Annick Borquez, Matthew Hickman, Chris Beyrer & Natasha K Martin. (2018) Potential impact of implementing and scaling up harm reduction and antiretroviral therapy on HIV prevalence and mortality and overdose deaths among people who inject drugs in two Russian cities: a modelling study. The Lancet HIV 5:10, pages e578-e587.
Crossref
Crossref
Joseph A. Ladapo, Marc R. Larochelle, Alexander Chen, Melissa M. Villalon, Stefanie Vassar, David Y. C. Huang & John N. Mafi. (2018) Physician Prescribing of Opioids to Patients at Increased Risk of Overdose From Benzodiazepine Use in the United States. JAMA Psychiatry 75:6, pages 623.
Crossref
Crossref
Robyn Dwyer, Anna Olsen, Carrie Fowlie, Chris Gough, Ingrid van Beek, Marianne Jauncey, Nicholas Lintzeris, Grace Oh, Jane Dicka, Craig L. Fry, Jeremy Hayllar & Simon Lenton. (2018) An overview of take-home naloxone programs in Australia. Drug and Alcohol Review 37:4, pages 440-449.
Crossref
Crossref
Sue Langham, Antony Wright, James Kenworthy, Richard Grieve & William C.N. Dunlop. (2018) Cost-Effectiveness of Take-Home Naloxone for the Prevention of Overdose Fatalities among Heroin Users in the United Kingdom. Value in Health 21:4, pages 407-415.
Crossref
Crossref
Rebecca McDonald, Nancy D. Campbell & John Strang. (2017) Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids—Conception and maturation. Drug and Alcohol Dependence 178, pages 176-187.
Crossref
Crossref
Alexander Y. Walley, Debbie M. Cheng, Emily K. Quinn, Elena Blokhina, Natalia Gnatienko, Christine E. Chaisson, Evgeny Krupitsky, Philip O. Coffin & Jeffrey H. Samet. (2017) Fatal and non-fatal overdose after narcology hospital discharge among Russians living with HIV/AIDS who inject drugs. International Journal of Drug Policy 39, pages 114-120.
Crossref
Crossref
Andrew Deonarine, Ashraf Amlani, Graham Ambrose & Jane A. Buxton. (2016) Qualitative assessment of take-home naloxone program participant and law enforcement interactions in British Columbia. Harm Reduction Journal 13:1.
Crossref
Crossref
Rebecca McDonald & John Strang. (2016) Are take‐home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria. Addiction 111:7, pages 1177-1187.
Crossref
Crossref
Kinna Thakarar, Zoe M Weinstein & Alexander Y Walley. (2016) Optimising health and safety of people who inject drugs during transition from acute to outpatient care: narrative review with clinical checklist. Postgraduate Medical Journal 92:1088, pages 356-363.
Crossref
Crossref
Joanne Csete, Adeeba Kamarulzaman, Michel Kazatchkine, Frederick Altice, Marek Balicki, Julia Buxton, Javier Cepeda, Megan Comfort, Eric Goosby, João Goulão, Carl Hart, Thomas Kerr, Alejandro Madrazo Lajous, Stephen Lewis, Natasha Martin, Daniel Mejía, Adriana Camacho, David Mathieson, Isidore Obot, Adeolu Ogunrombi, Susan Sherman, Jack Stone, Nandini Vallath, Peter Vickerman, Tomáš Zábranský & Chris Beyrer. (2016) Public health and international drug policy. The Lancet 387:10026, pages 1427-1480.
Crossref
Crossref
Traci C. Green, Sarah Bowman, Corey Davis, Cristina Los, Kimberly McHugh & Peter D. Friedmann. (2015) Discrepancies in addressing overdose prevention through prescription monitoring programs. Drug and Alcohol Dependence 153, pages 355-358.
Crossref
Crossref
Adam J Visconti, Glenn-Milo Santos, Nikolas P. Lemos, Catherine Burke & Phillip O Coffin. (2015) Opioid Overdose Deaths in the City and County of San Francisco: Prevalence, Distribution, and Disparities. Journal of Urban Health 92:4, pages 758-772.
Crossref
Crossref
Simon Lenton, Paul Dietze, Anna Olsen, Nicole Wiggins, David McDonald & Carrie Fowlie. (2015) Working together: Expanding the availability of naloxone for peer administration to prevent opioid overdose deaths in the Australian Capital Territory and beyond. Drug and Alcohol Review 34:4, pages 404-411.
Crossref
Crossref
Richard J. Bodnar. (2014) Endogenous opiates and behavior: 2013. Peptides 62, pages 67-136.
Crossref
Crossref
D. Tzemis, D. Al-Qutub, A. Amlani, S. Kesselring & J. A. Buxton. (2014) A quantitative and qualitative evaluation of the British Columbia Take Home Naloxone program. CMAJ Open 2:3, pages E153-E161.
Crossref
Crossref